$2.31T
Total marketcap
$106.39B
Total volume
BTC 49.83%     ETH 15.53%
Dominance

STAAR Surgical Company SR3.F Stock

47.98 EUR {{ price }} 1.266354% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
2.34B EUR
LOW - HIGH [24H]
47.98 - 47.98 EUR
VOLUME [24H]
40 EUR
{{ volume }}
P/E Ratio
119.95
Earnings per share
0.4 EUR

STAAR Surgical Company Price Chart

STAAR Surgical Company SR3.F Financial and Trading Overview

STAAR Surgical Company stock price 47.98 EUR
Previous Close 46.6 EUR
Open 47.79 EUR
Bid 47.82 EUR x 34300
Ask 48.42 EUR x 33000
Day's Range 47.79 - 47.79 EUR
52 Week Range 43.77 - 108.25 EUR
Volume 50 EUR
Avg. Volume 2 EUR
Market Cap 2.31B EUR
Beta (5Y Monthly) 1.179577
PE Ratio (TTM) 79.65
EPS (TTM) 0.4 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 147 EUR

SR3.F Valuation Measures

Enterprise Value 2.16B EUR
Trailing P/E 79.65
Forward P/E 62.064938
PEG Ratio (5 yr expected) 10.93
Price/Sales (ttm) 7.837444
Price/Book (mrq) 6.8144875
Enterprise Value/Revenue 7.322
Enterprise Value/EBITDA 54.814

Trading Information

STAAR Surgical Company Stock Price History

Beta (5Y Monthly) 1.179577
52-Week Change -18.28%
S&P500 52-Week Change 20.43%
52 Week High 108.25 EUR
52 Week Low 43.77 EUR
50-Day Moving Average 58.02 EUR
200-Day Moving Average 63.83 EUR

SR3.F Share Statistics

Avg. Volume (3 month) 2 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 48.33M
Float 39.2M
Short Ratio N/A
% Held by Insiders 0.72%
% Held by Institutions 101.89%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 30, 2023

Profitability

Profit Margin 10.81%
Operating Margin (ttm) 11.77%
Gross Margin 78.61%
EBITDA Margin 13.35%

Management Effectiveness

Return on Assets (ttm) 5.63%
Return on Equity (ttm) 10.35%

Income Statement

Revenue (ttm) 294.72M EUR
Revenue Per Share (ttm) 6.13 EUR
Quarterly Revenue Growth (yoy) 16.30%
Gross Profit (ttm) 223.38M EUR
EBITDA 39.37M EUR
Net Income Avi to Common (ttm) 31.86M EUR
Diluted EPS (ttm) 0.6
Quarterly Earnings Growth (yoy) -71.79%

Balance Sheet

Total Cash (mrq) 203.85M EUR
Total Cash Per Share (mrq) 4.22 EUR
Total Debt (mrq) 31.91M EUR
Total Debt/Equity (mrq) 9.41 EUR
Current Ratio (mrq) 6.648
Book Value Per Share (mrq) 7.013

Cash Flow Statement

Operating Cash Flow (ttm) 35.23M EUR
Levered Free Cash Flow (ttm) 8.17M EUR

Profile of STAAR Surgical Company

Country Germany
State CA
City Lake Forest
Address 25651 Atlantic Ocean Drive
ZIP 92630
Phone 626 303 7902
Website https://www.staar.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 882

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Q&A For STAAR Surgical Company Stock

What is a current SR3.F stock price?

STAAR Surgical Company SR3.F stock price today per share is 47.98 EUR.

How to purchase STAAR Surgical Company stock?

You can buy SR3.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for STAAR Surgical Company?

The stock symbol or ticker of STAAR Surgical Company is SR3.F.

Which industry does the STAAR Surgical Company company belong to?

The STAAR Surgical Company industry is Medical Instruments & Supplies.

How many shares does STAAR Surgical Company have in circulation?

The max supply of STAAR Surgical Company shares is 48.87M.

What is STAAR Surgical Company Price to Earnings Ratio (PE Ratio)?

STAAR Surgical Company PE Ratio is 119.95000000 now.

What was STAAR Surgical Company earnings per share over the trailing 12 months (TTM)?

STAAR Surgical Company EPS is 0.4 EUR over the trailing 12 months.

Which sector does the STAAR Surgical Company company belong to?

The STAAR Surgical Company sector is Healthcare.